» Articles » PMID: 38268969

Synergistic Cytotoxicity of Extracts of Chaga Mushroom and Microalgae Against Mammalian Cancer Cells In Vitro

Overview
Publisher Wiley
Date 2024 Jan 25
PMID 38268969
Authors
Affiliations
Soon will be listed here.
Abstract

Chaga mushroom () contains bioactive metabolites and has been used to treat various ailments, including cancer. Similarly, marine microalgae are considered a sustainable food supplement with anticancer and antioxidant properties. This study investigated the cytotoxicity of different extracts prepared from and microalgae using cultured human and canine cancer cell lines (MCF-7, HepG2, HOS, D-17, and DH-82). MTS cell viability assay was used to study the cytotoxicity of and microalgae extracts, and a synergy matrix effect was used to study the combined effect of the extracts. Isobologram analysis and the highest single agent synergy model were applied to study and validate the synergy between the extracts from and microalgae. Ethanol-based extraction and supercritical water extract significantly inhibited the growth of various mammalian cancer cells compared to aqueous extracts. Osteosarcoma cells were more susceptible to the supercritical extracts of and chlorophyll-free and sugar-free ethanol extracts of microalgae. A combination of ethanol-based extract and chlorophyll-free microalgae extract resulted in a synergistic interaction with various tested cancer cells. This study provides experimental evidence supporting the potential therapeutic application of and microalgae extracts with a synergistic effect to inhibit the growth of various mammalian cancer cells. Additional in vivo studies are required to fully explore possible therapeutic applications of these unique mixtures to be used in treating cancers.

Citing Articles

Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer.

Wang J, Beghelli D, Amici A, Sut S, DallAcqua S, Lupidi G Biomolecules. 2024; 14(11).

PMID: 39595631 PMC: 11591880. DOI: 10.3390/biom14111454.

References
1.
Castejon N, Marko D . Fatty Acid Composition and Cytotoxic Activity of Lipid Extracts from Produced by Green Technologies. Molecules. 2022; 27(12). PMC: 9230018. DOI: 10.3390/molecules27123710. View

2.
Balandaykin M, Zmitrovich I . Review on Chaga Medicinal Mushroom, Inonotus obliquus (Higher Basidiomycetes): Realm of Medicinal Applications and Approaches on Estimating its Resource Potential. Int J Med Mushrooms. 2015; 17(2):95-104. DOI: 10.1615/intjmedmushrooms.v17.i2.10. View

3.
Plehn S, Wagle S, Rupasinghe H . Chaga mushroom triterpenoids as adjuncts to minimally invasive cancer therapies: A review. Curr Res Toxicol. 2023; 5:100137. PMC: 10692653. DOI: 10.1016/j.crtox.2023.100137. View

4.
Lee H, Kim E, Kim S . Ethanol extract of Innotus obliquus (Chaga mushroom) induces G1 cell cycle arrest in HT-29 human colon cancer cells. Nutr Res Pract. 2015; 9(2):111-6. PMC: 4388940. DOI: 10.4162/nrp.2015.9.2.111. View

5.
Newman D, Cragg G, SNADER K . The influence of natural products upon drug discovery. Nat Prod Rep. 2000; 17(3):215-34. DOI: 10.1039/a902202c. View